Affle 3i Limited Grants 65,880 Stock Options to Employees Under ESOS 2021
Affle 3i Limited (formerly Affle (India) Limited) has granted 65,880 stock options to eligible employees under its Employee Stock Option Scheme – 2021, effective May 7, 2026, in compliance with SEBI (LODR) Regulations, 2015. The options cover 65,880 equity shares of face value Rs. 2 each, with the exercise price set at the closing market price on NSE on May 6, 2026. Vesting occurs in four equal tranches of 25% each at 12, 24, 36, and 48 months from the grant date, with each vested tranche exercisable within 1 year.
*this image is generated using AI for illustrative purposes only.
Affle 3i Limited (formerly known as Affle (India) Limited) has informed the stock exchanges of a fresh grant of stock options to its eligible employees under the Affle (India) Limited Employee Stock Option Scheme – 2021 ("Scheme"), in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The grant was made effective May 7, 2026, and the disclosure was submitted by Company Secretary & Compliance Officer Parmita Choudhury.
Stock Option Grant Details
The company has granted a total of 65,880 options to eligible employees, covering an equivalent number of equity shares of face value Rs. 2 each. The Scheme is compliant with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The key parameters of the grant are summarised in the table below:
| Parameter: | Details |
|---|---|
| Number of Options Granted: | 65,880 |
| Effective Grant Date: | May 7, 2026 |
| Equity Shares Covered: | 65,880 equity shares of face value Rs. 2 each |
| Exercise Price: | Closing market price on NSE on May 6, 2026 |
| Exercise Period: | 1 year from the date of vesting |
| SEBI Regulation Compliance: | SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 |
Vesting Schedule
The options will vest in a graded manner over a period of 48 months from the date of grant, subject to the terms and conditions specified in the Scheme. The vesting structure is as follows:
- 25% of the options granted will vest at 12 months from the date of grant
- 25% of the options granted will vest at 24 months from the date of grant
- 25% of the options granted will vest at 36 months from the date of grant
- 25% of the options granted will vest at 48 months from the date of grant
Each tranche, once vested, may be exercised within 1 year from the respective date of vesting.
Regulatory Disclosure
The company confirmed that no options have been exercised, lapsed, or cancelled as part of this grant, and no variation to the terms of the options has been made. There are no subsequent changes or cancellations to report at this stage. The disclosure was made in accordance with applicable SEBI listing regulations and the Master Circular issued by SEBI, ensuring transparency with shareholders and market participants.
Historical Stock Returns for Affle 3i
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.61% | +1.37% | +5.01% | -11.50% | -13.65% | +40.71% |
How might the 48-month vesting schedule impact employee retention rates at Affle India, particularly given the competitive talent landscape in the adtech sector?
What is the total outstanding ESOP pool under the 2021 Scheme, and how does this latest grant of 65,880 options affect potential equity dilution for existing shareholders?
Given Affle India's recent rebranding to 'Affle 3i Limited,' how could the company's strategic growth plans influence the attractiveness of these stock options if the share price appreciates significantly over the 48-month vesting period?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
